We do have, obviously, two vaccines that are showing the most promise, the Pfizer vaccine and the Moderna vaccine. Canada has purchased millions of doses of both, and both have applied to Health Canada for rolling regulatory approval. This is exciting news. The regulatory approval has been, as you know, accelerated to make sure that we can review data as the manufacturers provide it that so that we don't have to wait until the conclusion of the clinical trials.
All of that is good news. Of course, it would be irresponsible for me to give you a precise date, because much of that depends on the manufacturers' processes and the regulatory review process, but certainly we're optimistic that we should be able to see doses in Q1. We'll be working really hard with the manufacturers to hopefully see that success.